Savvy pharma companies will use the US DSCSA enforcement postponement
for enhanced — not deferred — implementation of track & trace systems. Dave Harty, head of Professional Services for Adents, tells us more…
Here, Giovanni Rizzo, PhD, MBA, chief of Innovation Division, Z-Cube, reveals what life science start-ups should bear in mind when looking for funding.
With the forthcoming regulatory changes set to come into force over the next couple of years in pharma, management practices will surely be tested. In this article, Tom Nichols, Quanticate, details some of the challenges the industry will face.
Master data management promises an efficient, definitive way to address the demands of the forthcoming ISO IDMP standards for product information recording. What is involved in practice though, and how can companies ensure the investment pays off?
Pharmacovigilance is a dynamic clinical and scientific discipline that has had an important impact on the public health environment. Madalina Huruba, ELC Group, goes into the history and the necessity of an effective pharmacovigilance system
In this case study, IMA Active and Zambon discuss how the Cyclops tumble bin blender assisted the formulation and blending from laboratory scale while following recommended guidelines.
Jamie Clayton, operations director at Freeman Technology, explains how comprehensive, process relevant characterisation of wet granules can lead to control of tablet CQAs and assist design space definition in the manufacture of an OTC medicine.
Gregor Deutschle, global business development manager for SCHOTT, speaks about how small and flexible means fast and profitable in pharma packaging and he reveals what this shift in manufacturing means for the industry and consumers.
As people search for healthcare information online more frequently and the digital market keeps growing the boundary between offline & online is becoming more blurred for pharma. Jake Holyoak from Mediaworks details the key challenges & opportunities
Robert Gaertner, director of strategy for quality at Veeva Systems in Europe, reveals the top five reasons why quality management should be moved to the cloud.
In the second part of the CPhI Worldwide Annual Report it has been revealed that the trend towards the increased use of modern manufacturing processes and quality systems is occurring very slowly and the current drugs pipeline is discouraging.
A recent survey has revealed the extent to which pharma businesses are failing to report data breaches. Here, Dominic Johnstone, head of Information Management Services at Crown Records Management, discusses the shocking results.
